Clinica Ars Medica

Dr. med. Valentina Bianchi Galdi

FTGS expert in tobacco counselling and treatment
Medical Examiner of Divers (MED), member SUHMS
General Medicine, FMH member

Languages

IT EN

Areas of specialisation (1)

General medicine

Download CV

Contact me

Hospital (1)

Ars Medica Centro dello Sport c/o Centro Ambrosart
Via Cantonale 38
6828 Manno

vbianchigaldi@arsmedica.ch

+41 91 611 64 80

Education

Covid-19 and Tobacco Use Certificate. John Hopkins Bloomberg School of Public Health, Institute for Global Tobacco Control, Baltimore, MD (USA)

Level II Certificate "The Individual Treatment of Tobacco Use". Italian Society of Tobaccology Nsmt, National School Of Medical Tobaccology.

Level I Certificate "Brief motivational counselling for tobacco addiction". Italian Society of Tobaccology Nsmt, National School Of Medical Tobaccology

Certificate "Motivational interviewing in health care", Psychwire (by Dr. Stephen Rollnick and Dr. William Miller)

Diploma FTGS/GNTH "expertin für nikotinberatung & tabakentwöhnung" forum tabakprävention und behandlung der tabakabhängigkeit in gesundheitsinstitutionen schweiz/the global network for tobacco free healthcare services, Zürich (ch)

Diploma "Expertin Für Nikotinberatung & Tabakentwöhnung Ftgs/Gnth" Forum Tabakprävention Und Behandlung Der Tabakabhängigkeit In Gesundheitsinstitutionen Schweiz/The Global Network For Tobacco Free Healthcare Services, Zürich (CH)

ENSP Certificate "The European Network For Smoking Prevention's Accredited Curriculum On Tobacco Treatment". European Network For Smoking And Tobacco Prevention (ENSP) And European Accreditation Council For Continuing Medical Education (EACCME)

Erasmus + Programme Of The European Union Certificate "Smoking Cessation Advice: Healthcare Professional Training". In coll. with the University of Birmingham (UK), the University of Bordeaux (F), the University of Milan (I), the Cooperativa de Ensiño Superior Politécnico E Universitario/Uics - Istituto Universitàrio Da Ciências Da Saùde di Gandra (P) and the University of Santiago de Compostela (E)

"Learning from the Experts: A Course for Healthcare Professionals". John Hopkins Bloomberg School Of Public Health, Institute For Global Tobacco Control, Baltimore, MD (USA)

"Global Tobacco Control: Learning from the Experts" Certificate. John Hopkins Bloomberg School of Public Health, Institute for Global Tobacco Control, Baltimore, MD (USA)

MCSCPD Certificate "Connecting with Patients for Tobacco Free Living". Mayo Clinic School of Continuous Professional Development, Mayo Clinic College of Medicine and Science, Rochester, MN (USA)

OTRU (Ontario Tobacco Research Unit) Certificate "Tobacco and Public Health: from Theory To Practice". In coll. with University of Toronto, Dalla Lana School of Public Health, Canada

Course 'Stop tobacco counselling - a new paradigm in NCD management'. National Stop Smoking Programme, Federal Office of Public Health, Bern (CH)

CTU-EOC certificate/Swissmedic Good Clinical Practice (GCP) for Investigators

General medical qualification, FMH

FMH-SGMO examination Medical Oncology

Summer School in Public Health Policy, Economics and Management "Economic Evaluation and health Care Decision making". Università della Svizzera Italiana, Faculty of Economics, Institute of Microeconomics and Public Economics MecoP, Lugano (CH)

Recognition of federal medical title, MEBEKO

SSMCP certificate in palliative care level A

SUHMS Certificate "Medical Examiner of divers".

Certification "improving communication" for doctors

Swiss Lung League Course "Vivre sans tabac - conseil au fumeur". Lugano (CH)

ACLS (Advanced Cardiac Life Support), CardioCentro Ticino, Lugano (CH)

Licensing as a Medical Surgeon, University of Pavia

Degree in Medicine and Surgery (110/110 cum laude), University of Pavia
Thesis: "Monitoring phagocytosis of polymorphonuclear leukocytes in severe surgical infections treated with high-dose IgG". Supervisor: Prof. Dr. med. L. Dominioni

Apprenticeship

Responsible for the pilot project "Sport snus-free" in coll. with FTHG (Federazione Ticinese Hockey su Ghiaccio), addressed to the Youth Sections

Contact person FTGS (Forum Tabakprävention in Gesundheitsinstitutionen Schweiz) for the canton of Ticino
National Strategy Group Member 'Strategie 2021 - 2028 Tabakprävention im Spitalsetting'.
Associate Member GNTH (The Global Network for Tobacco Free Healthcare Services)
Senior Member GNTH Gold Forum Jury (GNTH Gold Certificate)
Board Member FTGS
Referee for the indexed journal BMJ Open
Member of the Cantonal Action Programme (CAP) 'Prevention of alcohol, tobacco and related products 2021-2024

Lecturer within the HC Lugano Youth Section project "Health education for young athletes" (prevention programme on: smoking, alcohol, drugs, nutrition and doping)

Project manager and lecturer for the "Tobaccology Referee" courses for ENT health personnel (EOC) as part of the pilot project "ENT: towards a smoke-free hospital".

Member of the editorial board of the nationwide magazine Palliative.ch

Referee for the indexed journal Nephrology Dialysis and Transplantation

Co-supervisor of the medical degree thesis of Dr. med. Ph. Kessler entitled "Evaluation of vWF-cp, vWF:Ag and vWF:RCof in severe sepsis and septic shock". University of Bern, Faculty of Medicine, Department of Haematology, Bern.

Lab-Tutor at the Biochemistry course for the degrees in Pharmacy and Biochemistry. ETH Zentrum, Department of Biochemistry, Zurich

Assistant at the Medical Pathology course (Holder: Dr. med. P.F. Interdonato) for the Bachelor in Nursing Science at the University of Insubria, Varese (I)

Awards

2001: "Foundation for transfusion and transplantation research" Research Grant, Lugano (CH)

1996: Degree Award I.N.P.D.A.I., Rome (I)

1994: European Society for Organ Transplantation (E.S.O.T. - SANDOZ) Fellowship

Handouts Presentations

Bianchi Galdi V. Bronze für's Tessin - Erfolgsgeschichten des Ospedale Regionale di Lugano. Atti 8. Nikotintagung Vergangenheit und Zukunft, 24 September 2020, Aarau (CH)(oral presentation)

Majno P, Balzarotti R, Vitali G, Fournier I, Andres A, Bianchi V, Cristaudi A, Rosso R, Morel P, Rubbia-Brandt L, Toso C. Evaluating the quality of liver resection for colorectal liver metastases using a standardised definition of the difficulty to obtain R0 surgical margins. Proceedings European Surgical Association, 24th Annual Meeting. Bucharest, 4-6 May 2017(oral presentation)

Bianchi Galdi V, Balzarotti R, De Giorgi A, Majno P, Rosso R. Evaluation of quality and Outcome Quality Standards in pancreatic surgery at UCEP. Proceedings 6^ Giornata Della Ricerca Clinica della Svizzera Italiana. Lugano, 18.03.2016(oral presentation)

Bianchi Galdi V, Balzarotti R, Bihl F, Maffei M, Alerci M, Saletti P, Montemurro M, Majno P. UCEP (Cantonal Oncological, Radiological and Surgical Hepatobilio-Pancreatic Unit): an example of intra- and inter-cantonal collaboration. Proceedings EOC Congress. Lugano, Switzerland, April 2, 2015(oral presentation)

Bianchi Galdi V, Franzetti-Pellanda A, Spitale A, Valli MC, Ortelli L, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A. Quality indicators in radiation therapy for rectal cancer. A population-based study in Southern Switzerland. Proceedings 2nd ESTRO Forum. Geneva, Switzerland, April 19-23, 2013. Radiotherapy & Oncology 2013;106:S162(oral presentation)

Ortelli L, Bianchi Galdi V, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A, Spitale A and the QC3 Colorectal Working group. Quality of care indicators for colorectal cancer: results and assessments for Ticino from 2011 to 2012. Terza giornata della Ricerca Clinica della Svizzera Italiana. Lugano, Switzerland, March 22, 2013(oral presentation)

Bianchi V, Spitale A, Mazzucchelli L, Bordoni A. Quality indicators of clinical cancer care (QC3) in the territory of Canton Ticino: preliminary results in colorectal cancer. Proceedings 78th Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, November 8-10, 2012. Der Pathologe 2012;33:572(poster)

Bordoni A, Bianchi Galdi V, Mazzucchelli L, Spitale A and the QC3 CRC Working Group. Population-based quality indicators of cancer care: the QC3 pilot study on colorectal cancer patients. SAKK Symposium. Bern, Switzerland, November 1, 2012(oral presentation)

Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. Defining evidence-based clinical oncologic cares quality indicators. Proceedings ENCR 2012 Scientific Meeting. Cork, Ireland, September 19-20, 2012(poster)

Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. QC3: quality of comprehensive cancer care in Southern Switzerland. Proceedings 34th International Association of Cancer Registries (IARC) Conference. Cork, Ireland, September 17-19, 2012(poster)

Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. Quality of cancer care (QC3) in Southern Switzerland. Preliminary results of incident colo-rectal cancers in 2011. Proceedings XXXVII GRELL Congress. Porto, Portugal, May 16-18, 2012(poster)

Bianchi Galdi V, Spitale A, Mazzucchelli L, Mazzola P, Peverelli S, Bordoni A and the QC3 Working Group. QC3: Quality of cancer care in Canton Ticino. Seconda Giornata della Ricerca Clinica della Svizzera Italiana. Bellinzona, Switzerland, March 23, 2012(poster)

Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. Proceedings 77th Annual Meeting of the Swiss Society of Pathology. Luzern, Switzerland, November 10-12, 2011. Der Pathologe 2011;32:536-7(poster).

Bordoni A, Bianchi Galdi V, Mazzucchelli L, Spitale A. QoCC study: indicators of quality of cancer care in Southern Switzerland. Proceedings 33rd International Association of Cancer Registries (IARC) Conference. Balaclava, Mauritius, October 11-13, 2011(poster)

Bianchi Galdi V, Spitale A, Bordoni A and the QC3 Working Group. QC3 Pilot study: Quality of Care in the fight against Cancer. SAKK summer semi-annual meeting. Bern, Switzerland, June 23, 2011(oral presentation)

Bordoni A, Bianchi Galdi V, Spitale A, Mazzucchelli L and the QC3 Working Group. Population-based quality indicators of cancer care: the QC3 pilot study. SAKK summer semi-annual meeting. Bern, Switzerland, June 23, 2011(oral presentation)

Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. XXXVI GRELL Congress. Caen, France, June 1-3, 2011(poster)

Bianchi V, Celio D, Oudineche A, Mazzucchelli L, Saletti P, Rosso R. Bizarre cell leiomyoma of the duodenum: an entity of peculiar interest. Proceedings 96e Congrès Annuel de la Société Suisse de Chirurgie. Montreaux, Switzerland, June 10-12, 2009. Swiss Knife 2009; special edition: 68.60(poster)

Lutz HU, Stammler P, Bianchi V, Trüeb RM, Hunziker T, Burger R, Jelezarova E, Späth PJ. Intravenously applied IgG stimulates complement attenuation in dermatomyositis at the amplifying C3 convertase level. Proceedings American Academy of Allergy, Asthma and Immunology (AAAAI) 60th Anniversary MeetingJ. Denver, Colorado, USA, March 7-12, 2003. J Allerg Clin Immunol 2003;111(1):S316(oral presentation)

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for TTP. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S(oral presentation)

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S(oral presentation)

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for thrombotic thrombocytopenic purpura. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1): A6(oral presentation)

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1):A6(oral presentation)

Bianchi V, Kessler Ph, Zeerleder S, Alberio L and Lämmle B. von Willebrand factor (vWF) and von Willebrand factor-cleaving protease (vWF-cp) activity in severe sepsis and septic shock. Proceedings of the 7th Cardiovascular Biology and Clinical Implications Meeting. Interlaken, Switzerland, October 26-27, 2001(poster)

Dominioni L, Chiappa A, Bianchi V and Dionigi R. Sequential treatment of infected pancreatic necrosis with zip abdominal re-explorations, open abdomen and continuous lavage. Proceedings 10th Meeting of the Association of Academic Departments of Surgery in Europe (ADSE). Sigriswil, Bern, Switzerland, April 19-20, 1996(oral presentation).

Dominioni L, Bianchi V, Imperatori A and Dionigi R. In vitro effect of three generations of intravenous immunoglobulins on the opsonophagocytic function of neutrophils from severely septic patients. Proceedings Interlaken's Fourth Symposium on IVIG. Interlaken, Switzerland, June 11-13, 1996(oral presentation).

Imperatori A, Dominioni L, Bianchi V, Benevento A, Dionigi R. Use of high-dose polyvalent IgG in the therapy of severely septic surgical patients. Proceedings 97th Congress Italian Society of Surgery. Trieste, Italy, October 8-11, 1995(oral presentation).

Dominioni L, Gennari R, Minoia G, Imperatori A, Bianchi V, Dionigi R. Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins. Proceedings "8th Meeting of Academic Departments of Surgery in Europe (ADSE)". Castellfedels, Barcelona, Spain, March 25-26, 1994(oral presentation).

Dominioni L, Gennari R, Minoia G, Imperatori A, Bianchi V, Dionigi R. Survival of septic patients related to initial sepsis score and therapy with high-dose polyvalent IgG. Proceedings XVIII Congresso Società Italiana di Ricerche in Chirurgia. Grado, Italy, September 1994(oral presentation)

Work Experience

Own practice, General Medicine and Tabaccology

Scientific Collaborator at the EOC - General Management, Support Area
Head of pilot project "ENT: towards a smoke-free hospital" (01.06.18-31.12.2019)

Scientific Collaborator at the EOC - EOQUAL (Quality and Patient Safety Service), Lugano Regional Hospital
Scientific Physician UCEP (Cantonal Hepato-Bilio-Pancreatic Unit), EOC

Scientific Collaborator and Project Coordinator, Cantonal Cancer Registry (Director: Dr. med. A. Bordoni), Cantonal Institute of Pathology, Locarno.
Project: "Indicators of Quality of Cancer Care (QC3) in Southern Switzerland".
The study was sponsored by: Krebsforschung Schweiz, grant no. KFS-02668-08-2010; ABREOC (Advisory Board Ente Ospedaliero Bellinzona), grant no. ABREOC 10/2010, Swiss Academy of Medical Sciences, grant no. KZS 3/11; Zonta Club Locarno.

EOC - Ospedale Regionale Bellinzona e Valli, Faido site, Department of Internal Medicine (Resp.: Dr. med. A. Valenti)

EOC - IOSI (Oncological Institute of Italian Switzerland, Director: Prof. Dr. med. M. Ghielmini), Bellinzona.

EOC - Regional Hospital of Lugano, Department of Internal Medicine (Director: Prof. Dr. med. A. Cerny), Lugano.

Researcher at the Inselspital Bern, Department of Haematology, Laboratory of Experimental Haematology (Director: Prof. Dr. med. B. Lämmle), Bern.

Carried out projects:

"Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies".
"Von Willebrandfactor-cleaving protease in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura (TTP)"
"Von Willebrandfactor (vWF) and von Willebrand factor-cleaving protease (vWF-cp) activity in severe sepsis and septic shock"

The studies were partly sponsored by a grant from the 'Foundation for Transfusion and Transplantation Research', Lugano.

Researcher at the ETH-Zentrum-Swiss Federal Institute of Technology, Department of Biochemistry (Head: H. Lutz, Ph.D.), Zurich.
Project: 'Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level'.
The study was sponsored by: KTI grants no. 3189.1 and 3772.1 of ZLB Central Laboratory, Blood Transfusion Services of the Swiss Red Cross, Bern, and by the Swiss Government.

Consultant Physician at the "Beccaria" Analysis Laboratory (Director: Dr. biol. B. Calegari), Varese (I)

Researcher at the Department of Biotechnology (DIBIT), Immunochemistry Unit (Head: Dr. med. Paolo Dellabona and Giulia Casorati, Ph.D.), San Raffaele Hospital, Milan.
Project : 'Characterization of new mPBP-like, mPF4-like and hIP10-like chemokines in tumour angiogenesis'.

Medical Specialist in General Surgery with Oncological Address at the School of Specialisation in General Surgery of the University of Pavia, Varese (I) Branch (Director: Prof. Dr. med. R. Dionigi) and at the Laboratory of Experimental Surgery of the University of Pavia, Varese (I) Branch (Director: Prof. Dr. med. R. Dionigi).

Projects carried out:

"In vitro effect of intravenous immunoglobulins (IVIG) on the opsonophagocytic function of neutrophils from severely septic patients".
"Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins".
"Immediate postoperative enteral nutrition, sequential treatment of infected pancreatic necrosis with zip abdominal re-explorations, open abdomen and continuous lavage".

Medical Candidate and Intern at the Department of General Surgery, University of Pavia, Varese (I) Campus (Director: Prof. Dr. med. R. Dionigi) and at the Laboratory of Experimental Surgery, University of Pavia, Varese (I) Campus (Director: Prof. Dr. med. R. Dionigi).

Visiting Student (European Society for Organ Transplantation, E.S.O.T. Fellowship), Ludwig-Maximilians-Universität, Klinikum Großhadern, Institute of Surgical Research (Director: Prof. Dr. med. vet. C. Hammer).

Memberships

FMH
OMCT (Medical Association of the Canton of Ticino)
ASMAC (Swiss Association of Medical Assistants and Clinic Managers)
FTGS (Forum Tabakprävention in Gesundheitsinstitutionen Schweiz), Board Member
GNTH (The Global Network for Tobacco Free Heathcare Services), Associate Member
ENSP (European Network for Smoking and Tobacco Prevention)
SITAB (Italian Society of Tobaccology)
ESMO (European Society of Medical Oncology)
SGAIM (Swiss Society of Internal Medicine)
SUHMS (Swiss Underwater and Hyperbaric Medical Society)
SSMCP (Swiss Society of Palliative Care Medicine)

Publications

Peer-reviewed journals:

Bianchi V, Spitale A, Ortelli L, Mazzucchelli L, Bordoni A and the QC3 CRC Working Group. Quality indicators of clinical cancer care (QC3) in colorectal cancer. BMJ Open 2013;3:e002818. doi:10.1136/bmjopen-2013-002818.

Lutz HU, Stammler P, Bianchi V, Trueb RM, Hunziker T, Burger R, Jelezarova E, Spath PJ. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 2004;103(2):465-472

Studt JD, Kremer Hovinga JA, Alberio L, Bianchi V, Lammle B. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. Swiss Med Wkly 2003;133(23-24):325-332

Winkler A, Kremer Hovinga JA, Bianchi V, Studt JD, Lämmle B. Schistocytic anaemia, severe thrombocytopenia and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Hämostaseologie 2003;23(3):103-108

Lämmle B, Bianchi V, Alberio L, Furlan M. ADAMTS13 and thrombotic thrombocytopenic purpura: Letter to the Editor. Blood 2002;100:3839-3842

Bianchi V, Robles R, Alberio L, Furlan M and Lämmle B. Von Willebrand factor-cleaving protease in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura (TTP). Blood 2002;100:710-713

Dominioni L, Chiappa A, Bianchi V, Interdonato PF, Festi L, Carcano G, Benevento A, Dionigi R. Infected pancreatic necrosis complicated by multiple organ failure. Prospective study of sequential treatment with abdominal re-explorations, open abdomen and continuous closed lavage. Hepato-Gastroenterology 1997;44:968-974

Dominioni L, Bianchi V, Imperatori A, Minoia G, Dionigi R. High-dose intravenous IgG for treatment of severe surgical infections. Dig Surg 1996;13:430-434

Dominioni L, Chiappa A, Interdonato F, Festi L, Carcano G, Bianchi V, Frattini V, Peloni G, Dionigi R. Sequential treatment of infected pancreatic necrosis with zip abdominal re-explorations, open abdomen and continuous lavage. Br J Surg 1996;83:863-864

Dominioni L, Chiappa A, Gavinelli M, Bianchi V, Dionigi R. Two-stage surgical treatment of rupture of the esophagus (Boerhaave's syndrome) complicated by mediastinal abscess. J Em Surg 1995;18:68-72

Dominioni L, Berizzi F, Besozzi MC, Dozio E, Imperatori A, Bianchi V, Dionigi R. Immediate postoperative enteral nutrition. Chir Italiana 1994; 46: 36-41

Gennari R, Dominioni L, Imperatori A, Bianchi V, Maroni P, Dionigi R. Alterations in lymphocyte subsets as prognosticators of postoperative infections. Eur J Surg 1994;161:493-499

Dominioni L, Gennari R, Minoia G, Imperatori A, Bianchi V, Dionigi R. Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins. J R Coll Surg Edinb 1994;39:380

Abstracts published in peer-review journals:

Balzarotti R, Vitali G, Fournier I, Andres A, Cristaudi A, Toso C, Bianchi V, Rosso R, Morel P, Rubbia-Brandt L, Majno P. Evaluating the quality of liver resection for colorectal liver metastases using a standardised definition of the difficulty to obtain R0 surgical margins. BJS 2016;103(4):16

Bianchi Galdi V, Franzetti-Pellanda A, Spitale A, Valli MC, Ortelli L, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A. Quality indicators in radiation therapy for rectal cancer. A population-based study in Southern Switzerland. Proceedings 2nd ESTRO Forum. Geneva, Switzerland, April 19-23, 2013. Radiotherapy & Oncology 2013;106:S162

Bianchi V, Spitale A, Mazzucchelli L, Bordoni A. Quality indicators of clinical cancer care (QC3) in the territory of Canton Ticino: preliminary results in colorectal cancer. Proceedings 78th Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, November 8-10, 2012. Der Pathologe 2012;33:572

Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. Proceedings 77th Annual Meeting of the Swiss Society of Pathology. Luzern, Switzerland, November 10-12, 2011. Der Pathologe 2011;32:536-7

Bianchi V, Celio D, Oudineche A, Mazzucchelli L, Saletti P, Rosso R. Bizarre cell leiomyoma of the duodenum: an entity of peculiar interest. Proceedings 96e Congrès Annuel de la Société Suisse de Chirurgie. Montreaux, Switzerland, June 10-12, 2009. Swiss Knife 2009; special edition: 68.60

Lutz HU, Stammler P, Bianchi V, Trüeb RM, Hunziker T, Burger R, Jelezarova E, Späth PJ. Intravenously applied IgG stimulates complement attenuation in dermatomyositis at the amplifying C3 convertase level. Proceedings American Academy of Allergy, Asthma and Immunology (AAAAI) 60th Anniversary MeetingJ. Denver, Colorado, USA, March 7-12, 2003. J Allerg Clin Immunol 2003;111(1):S316

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for TTP. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for thrombotic thrombocytopenic purpura. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1): A6

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1):A6

Book chapters:

Bianchi V. Wound repair. In: Carcano G, Dionigi R Eds. Wounds. Elsevier Masson Italy 1998;33-39

Dominioni L, Bianchi V, Chiappa A, Ochetti A. Lungs. In: Dionigi R Ed. Surgery, 2nd edition. Elsevier Masson Italy 1997;648-674

Dominioni L, Alberio MG, Bianchi V. Pleura. In: Dionigi R Ed. Surgery, 2nd edition. Elsevier Masson Italy 1997;616-627

Dominioni L, Ochetti A, Bianchi V. Thoracic wall. In: Dionigi R Ed. Surgery, 2nd edition. Elsevier Masson Italy 1997;609-615

Gaeta L, Benevento A, Chiappa A, Carcano G, Barbera D, Bianchi V, Dionigi R. Surgical treatment of carcinoma of the anus. In: Natale C, Galeazzi R, Battelli T Eds. Intestinal tumours. AM Editions 1997;213-222

Dominioni L, Berizzi F, Dozio E, Imperatori A, Bianchi V, Dionigi R. Physiopathology of immediate postoperative enteral nutrition (NEPI). In: Bogen M, Malacrida R, Martinoli S Eds. Artificial nutrition between biological desires and nature's limitation. Alice 1996;61-66

Dominioni L, Bianchi V, Imperatori A, Dionigi R. Use of intravenous immunoglobulin in patients at high risk of bacterial infections. In: Kazatchkine MD, Morell A Eds. Intravenous Immunoglobulin Research and Therapy, New York: the Partenon Publishing Group Ltd. 1996;209-213

Dominioni L, Bianchi V, Imperatori A, Minoia G, Dionigi R. Completed clinical trials of high-dose polyvalent IgG (Sandoglobulin®) in surgical infections. In: Faist E, Baue AE, Schildberg FW Eds. The immune consequences of trauma, shock and sepsis - Mechanisms and therapeutic approaches. MOF, MODS and SIRS - Concepts, clinical correlates and therapy. Pabst Science Publishers, 1996. Vol. 2/2, pp.1078-83

Dominioni L, Chiappa A, Peloni G, Bianchi V. Bacterial and fungal sepsis in surgery. In: Proceedings 97° Congresso Società Italiana di Chirurgia. Trieste, October 8-11, 1995. Pozzi ed., Vol. 2°, pp. 247-57

Dionigi R, Dominioni L, Benevento A, Carcano G, Imperatori A, Bianchi V. Use of staplers and of early post-operative enteral feeding for pancreatic resections. In: Proceedings of the Italian Chapter American College of Surgeons, 1995, pp. 93-100

Dominioni L, Bianchi V, Imperatori A. Severely septic surgical patients. In: Kazatchkine MD Ed. Intravenous Immunoglobulin Therapy. Clinical benefits and future prospects. The Partenon Publishing Group Ltd., New York, 1995; pp. 85-88.

Other publications:

Bianchi Galdi V. "What shall I prepare for you?" - Practical online tips for coping with feeding difficulties in the cancer patient. Palliative-ch 2012;3:26-30

Bianchi V, Spitale A, Mazzucchelli L, Bordoni A, and the QC3 Working Group. Quality indicators of clinical cancer care (QC3) in the territory of Canton Ticino. A population-based study. Schweizer Krebsbulletin 2012;3:205-8

Bianchi Galdi V. Burnout and resilience. Palliative-ch 2011:4:5-11

Bianchi Galdi V, Spitale A, Bordoni A. Quality indicators in cancer care: QC3 study. Tribuna Medica Ticinese 2011; 76(1): 51-55

Editorials:

Bianchi Galdi V, Gamondi C. Editorial. Palliative-ch 2012;3:4

Bianchi Galdi V, Gamondi C. Editorial. Palliative-ch 2011:4:4

Bianchi Galdi V, Gamondi C. Editorial. Palliative-ch 2010;2:4

Edited journals:

Bianchi Galdi V, Gamondi C. Palliative-ch 'Nutrition in palliative care'. 2012;3:4

Bianchi Galdi V, Gamondi C. Palliative-ch 'Caring for the Carers. Burnout'. 2011:4:1-61

Bianchi Galdi V, Gamondi C. Palliative-ch "Chronic diseases". 2010;2:1-80

Research

2011 - 2013. Scientific Collaborator and Project Coordinator, Cantonal Cancer Registry (Director: Dr. med. A. Bordoni), Cantonal Institute of Pathology, Locarno.
Project: "Indicators of Quality of Cancer Care (QC3) in Southern Switzerland".
The study was sponsored by: Krebsforschung Schweiz, grant no. KFS-02668-08-2010; ABREOC (Advisory Board Ente Ospedaliero Bellinzona), grant no. ABREOC 10/2010, Swiss Academy of Medical Sciences, grant no. KZS 3/11; Zonta Club Locarno.

2001 - 2002. Researcher at Inselspital Bern, Department of Haematology, Laboratory of Experimental Haematology (Director: Prof. Dr. med. B. Lämmle), Bern.
Carried out projects:
- "Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies".
- "Von Willebrand factor-cleaving protease in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura (TTP)"
- 'Von Willebrand factor (vWF) and von Willebrand factor-cleaving protease (vWF-cp) activity in severe sepsis and septic shock'
The studies were partly sponsored by a grant from the "Foundation for Transfusion and Transplantation Research", Lugano.

1999 - 2000. Researcher at theETH-Zentrum-Swiss Federal Institute of Technology, Department of Biochemistry (Head: H. Lutz, Ph.D.), Zurich.
Project: 'Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level'.
The study was sponsored by: KTI grants no. 3189.1 and 3772.1 of ZLB Central Laboratory, Blood Transfusion Services of the Swiss Red Cross, Bern, and by the Swiss Government.

1997 - 1998. Researcher at the Department of Biotechnology (DIBIT), Immunochemistry Unit (Head: Dr. med. Paolo Dellabona and Giulia Casorati, Ph.D.), San Raffaele Hospital, Milan.
Project: 'Characterization of new mPBP-like, mPF4-like and hIP10-like chemokines in tumour angiogenesis'.

1995 - 1997. Laboratory of Experimental Surgery, University of Pavia, Varese (I) Branch (Director: Prof. Dr. med. R. Dionigi).
Projects performed:
- "In vitro effect of intravenous immunoglobulins (IVIG) on the opsonophagocytic function of neutrophils from severely septic patients".
- "Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins".
- "Immediate postoperative enteral nutrition, sequential treatment of infected pancreatic necrosis with zip abdominal re-explorations, open abdomen and continuous lavage".

1994. Visiting Student (E.S.O.T. Fellowship) at the Ludwig-Maximilians-Universität, Klinikum Großhadern, Institute of Surgical Research (Director: Prof. Dr. med. vet. C. Hammer).
Project: 'Cytological monitoring of heart and liver transplant patients'.